American Chemical Society

Vaccination

One vaccine dose enough for COVID-19 survivors

Two mRNA vaccines against COVID-19 have proven safe and effective in clinical trials, as well as in the millions of people who have been vaccinated so far. But how prior SARS-CoV-2 infection affects vaccine response, and ...

Biomedical technology

Creating a needle-free COVID-19 vaccine

Vaccines are mostly synonymous with needles, an efficient and effective way to provide immunity to myriad infections. As COVID-19 vaccination efforts roll out across the U.S. and the world, some experts believe that a vaccine ...

Diseases, Conditions, Syndromes

Toward a reliable oral treatment for sickle cell disease

For the millions of people worldwide who have sickle cell disease, there are only a few treatment options, which include risky bone marrow transplants, gene therapy or other treatments that address a subset of symptoms. Today, ...

Oncology & Cancer

An amyloid link between Parkinson's disease and melanoma

On the surface, Parkinson's disease—a neurodegenerative disorder—and melanoma—a type of skin cancer—do not appear to have much in common. However, for nearly 50 years, doctors have recognized that Parkinson's disease ...

Diseases, Conditions, Syndromes

Purifying the air to prevent COVID-19 transmission

The onset of the COVID-19 pandemic had people sharing an array of strategies for disinfection and disease prevention. The ensuing months showed that the SARS-CoV-2 virus is primarily spread through the air via contaminated ...

page 9 from 40